不裂唇的改良下颌下下颌骨切开入路在舌癌中的应用
回顾性比较43例舌鳞状细胞癌患者采用不裂唇的改良下颌下下颌骨切开(MSMM)入路与43例配对采用裂唇下颌骨切开(LSM)入路者的临床结局。两组均经口内联合入路整块切除肿瘤,肿瘤暴露良好并获R0切缘;复发率及吞咽、咀嚼、言语功能相似,MSMM组面部外观与再造评分及生活质量更优。
要点
- MSMM入路不裂唇,43例均经口内联合入路整块切除肿瘤,获良好暴露与R0切缘。
- MSMM组与LSM组肿瘤复发率及吞咽、咀嚼、言语功能相似。
- MSMM组面部外观与再造评分显著优于LSM组,生活质量更优。
核心结论
- 不裂唇的MSMM入路安全有效,在舌鳞状细胞癌患者中较LSM入路获得更好的生活质量。
研究设计与样本
- 回顾性研究,43例舌鳞状细胞癌患者采用不裂唇的MSMM入路手术,另匹配43例采用LSM入路者进行回顾分析。
主要发现
- MSMM入路与LSM入路均经口内联合入路整块切除肿瘤,肿瘤暴露良好并获R0切缘。
- 两组肿瘤复发率及吞咽、咀嚼、言语功能相似。
- MSMM入路组面部外观与再造评分显著优于LSM入路组。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Lip-splitting approach for oncologic resection and defect reconstruction of tongue squamous cell carcinoma (TSCC) needs modification to avoid unfavorable esthetic results. Forty-three patients with TSCC underwent surgery using the modified submandibular mandibulotomy(MSMM) approach without lip-splitting and another matched 43 patients using lip-splitting mandibulotomy (LSM) approach were reviewed retrospectively. Clinical outcomes evaluation consisted of tumor exposure, resection margin, surgical morbidity, locoregional recurrence, survival status, scar scores and quality of life (QOL). All the tumors were en bolc removed by MSMM approach and LSM approach through combined intraoral routes with excellent tumor exposure and R0 resection margins. Tumor recurrence rates and swallowing, chewing, speech were similar in both groups. The MSMM approach was associated with significantly better facial appearance and recreation than LSM approach. The MSMM approach without lip-splitting is safe and effective, achieves better QOL compared to LSM approach in patients with TSCC.
引用
- Wang Y, Zhou B, Liu Z, et al. Modified submandibular mandibulotomy approach without lip-splitting in tongue cancer. J Plast Reconstr Aesthet Surg. 2022. PMID: 36104264. doi:10.1016/j.bjps.2022.08.074
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。